SOC status:Duty analyst on shift

UK Cyber Defence
VulnerabilityModified

CVE-2017-12718

A Classic Buffer Overflow issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6.

EXPLOITHIGH 8.1EPSS 12.8%

Does this matter?

EPSS puts the probability of exploitation in the next 30 days at 12.8%, higher than 96% of all known CVEs. Patch or mitigate before the next change window.

Description

A Classic Buffer Overflow issue was discovered in Smiths Medical Medfusion 4000 Wireless Syringe Infusion Pump, Version 1.1, 1.5, and 1.6. A third-party component used in the pump does not verify input buffer size prior to copying, leading to a buffer overflow, allowing remote code execution on the target device. The pump receives the potentially malicious input infrequently and under certain conditions, increasing the difficulty of exploitation.

CVSS 3.0
8.1 HIGHCVSS:3.0/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
EPSS
12.78% probability · 96th percentile
Public exploits
1 in Exploit-DB · first 18 January 2018
CISA KEV
Not listed
Weakness
CWE-120, CWE-119
Affected
smiths-medical/medfusion 4000 wireless syringe infusion pump
Source
ics-cert@hq.dhs.gov
EPSS trend
0%8%15%21 September 2026: 10.77%22 September 2026: 12.78%27 October 2026: 12.78%21 September 202627 October 2026

EPSS moved from 10.8% on 21 September 2026 to 12.8% on 27 October 2026. The dashed line is the ten per cent mark our analysts treat as “patch before the next change window”.

Public exploits (1)

Entries in Exploit-DB that cite this CVE. Links go to the Exploit-DB page and to the file in the public repository; nothing is hosted here. A verified tick means the Exploit-DB team confirmed the exploit works against the stated version.

EDB-IDTitleTypePublishedVerified
EDB-43776source ↗Smiths Medical Medfusion 4000 - 'DHCP' Denial of Servicehardware · Scott Gayoudos18 January 2018no

References

Source: NVD record, EPSS from FIRST.org, KEV from CISA, exploits from Exploit-DB. Refreshed daily. Download this record as JSON.